Pacific Premier Bancorp, Inc. announced the appointment of Stephanie Hsieh as a director of the company, effective as of July 29, 2022. Hsieh is independent pursuant to applicable NASDAQ rules and has no material relationship with the Company. Hsieh has accepted appointments to serve initially on the Compensation and Enterprise Risk Committees of Pacific Premier's Board of Directors.

Hsieh joined Biocom California as Executive Director of the Los Angeles region in 2020. Prior to Biocom California, she co-founded Meditope Biosciences, Inc., where she served as CEO from 2012 to 2020 and where she currently serves as a non-executive director. Hsieh began her career as an intellectual property attorney, specializing in patent prosecution and litigation, and actively practiced law for a combined fifteen years.

She served in a variety of legal and business roles in the biotechnology and biopharmaceutical industries, including as a senior executive at Impax Laboratories, Inc. from 2007 to 2011. Hsieh currently serves on the Board of Directors of Meditope Biosciences, Inc. and Sydecar, Inc. In addition, she is active in the community, currently serving on the Boards of Directors of Girls, Inc., the Forsyth Institute, as Chair of the Wellesley Business Leadership Council, and on the Wellesley College Alumnae Association Board. Hsieh graduated magna cum laude and Phi Beta Kappa from Wellesley College, as a Harlan Fiske Stone Scholar from the Columbia University School of Law, and holds a master's degree in business administration from Stanford University's Graduate School of Business.